Table 1:

Clinical details of patients on VGB therapy and MRI changes

Patient No.	Sex	Diagnosis	Age at MRI (mo)	Duration of VGB at MRI (days)	Dose (mg) of VGB at time of MRI	Areas of T2 and/or Diffusion Hyperintensity
Patient No.	Sex	Diagnosis	Age at MRI (mo)	Duration of VGB at MRI (days)	Dose (mg) of VGB at time of MRI	GP	Thalamus	DB
1	M	Cryptogenic IS	8	49	1250	Yes	No	Yes
2	F	Cryptogenic IS	7	32	1400	Yes	No	No
3	M	Cryptogenic IS	8	67	1500	Yes	Yes	Yes
4	M	TSC	13	230	1375	Yes	No	No
5	M	Cryptogenic IS	13	17	1630	Yes	No	No
6	M	Cryptogenic IS	9	52	1250	Yes	Yes	Yes